95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-15.79%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-16.44%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-17.01%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-17.01%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-17.73%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-21.88%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-21.88%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.02%
Share reduction more than 1.5x FNV's 0.10%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.01%
Reduced diluted shares while FNV is at 0.10%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-50.24%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-15.45%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-32.66%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
5.30%
10Y revenue/share CAGR under 50% of FNV's 138.36%. Michael Burry would suspect a lasting competitive disadvantage.
17.64%
5Y revenue/share CAGR under 50% of FNV's 74.88%. Michael Burry would suspect a significant competitive gap or product weakness.
-28.00%
Negative 3Y CAGR while FNV stands at 9.03%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
13.22%
10Y OCF/share CAGR under 50% of FNV's 183.24%. Michael Burry would worry about a persistent underperformance in cash creation.
54.57%
5Y OCF/share CAGR at 50-75% of FNV's 77.45%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
-25.62%
Negative 3Y OCF/share CAGR while FNV stands at 9.63%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
18.59%
Below 50% of FNV's 277.43%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
235.00%
5Y net income/share CAGR similar to FNV's 223.97%. Walter Schloss might see both on parallel mid-term trajectories.
-23.01%
Negative 3Y CAGR while FNV is 12.15%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
61.85%
10Y equity/share CAGR in line with FNV's 65.60%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
29.21%
5Y equity/share CAGR at 75-90% of FNV's 37.56%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
22.22%
3Y equity/share CAGR at 75-90% of FNV's 27.61%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
46.20%
10Y dividend/share CAGR at 50-75% of FNV's 65.22%. Martin Whitman suspects the firm lags in returning cash to shareholders over the decade.
91.79%
5Y dividend/share CAGR above 1.5x FNV's 59.91%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
76.29%
3Y dividend/share CAGR above 1.5x FNV's 41.77%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
57.36%
Our AR growth while FNV is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-50.99%
Inventory is declining while FNV stands at 39.57%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.02%
Asset growth well under 50% of FNV's 1.14%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-0.06%
We have a declining book value while FNV shows 1.27%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-4.44%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-11.84%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.